BRAF and melanoma: Many of these mutants show a lower BRAF kinase activity toward MEK in vitro than that of the V600E mutant, explaining why these mutants are often classified as “low activity” or “impaired activity” mutants (for example, G469A and D594G are found frequently in mucosal melanomas).